Contraception
Volume 81, Issue 3 , Pages 177-180 , March 2010

Multipurpose prevention technologies for sexual and reproductive health: gaining momentum and promise

Received 20 November 2009 ,Accepted 20 November 2009.

References 

  1. Guttmacher Institute and United Nations Population Fund (UNFPA) . Adding It Up: The Benefits of Investing in Sexual and Reproductive Health Care. New York: AGI. Available at: http://www.guttmacher.org/pubs/addingitup.pdf2003;
  2. Stone A. Symposium Report: Advancing Prevention Technologies for Sexual and Reproductive Health. Available at: http://www.cami-health.com/APT2009/PDFs/report-aug09.pdf2009;
  3. Cates W, Steiner MJ. Dual protection against unplanned pregnancy and sexually transmitted infections: what is the best contraceptive approach?. Sex Transm Dis. 2002;29:168–174
  4. International Planned Parenthood Federation , University of California San Francisco , Joint United Nations Program on HIV/AIDS , UNFPA , World Health Organization . Sexual & reproductive health and HIV. Linkages: evidence review and recommendations. Available online at: http://data.unaids.org/pub/Agenda/2009/2009_linkages_evidence_review_en.pdf2009;
  5. Wilcher R, Petruney T, Reynolds HW, Cates W. From effectiveness to impact: contraception as an HIV prevention intervention. Sex Transm Infect. 2008;84(Suppl 2):ii54–ii60
  6. Feldblum PJ, Nasution MD, Hoke TH, et al. Pregnancy among sex workers participating in a condom intervention trial highlights the need for dural protection. Contraception. 2007;76:105–110
  7. Allsworth JE, Lewis VA, Peipert JF. Viral sexually transmitted infections and bacterial vaginosis: 2001–2004 National Health and Nutrition Examination Survey data. Sex Transm Dis. 2008;35:791–796
  8. Frost JJ, Singh S, Finer LB. US women's one-year contraceptive use patterns, 2004. Perspect Sex Reprod Health. 2007;39:48–55
  9. Glasier A, Gulmezoglu AM, Schmid GP, Moreno CG, Van Look PFA. Sexual and reproductive health: a matter of life and death. Lancet. 2006;368:1550–1551
  10. CDC . HIV/AIDS Surveillance Report 2003; (Vol. 15). Atlanta: US Department of Health and Human Services, CDC; 2005;
  11. The World Bank and International Monetary Fund. Global Monitoring Report 2009: A Development Emergency. 2009; Washington DC.
  12. Bosch FX, de Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers. 2007;23:213–227
  13. UNFPA . Empowering women to protect themselves: promoting the female condom in Zimbabwe. Available at: http://www.unfpa.org/public/cache/offonce/News/pid/3913;jsessionid=4FBD9DA8AD4EFB9F069224AC0EEB06702009;
  14. Verguet S, Young Holt B, Szeri A. Reframing behavioral acceptability of microbicide gel vehicles in conjunction with biophysical constraints. Presented at the 2009 Advancing Prevention Technologies for Sexual and Reproductive Health Symposium, Berkeley California. Available at: http://www.cami-health.com/APT2009/posters.html2009;
  15. Morrow K, Fava J, Rosen R, Kiser P, Katz D. Linking biophysical functions to user perceptions and acceptability in preclinical product development. Presented at the 2009 Advancing Prevention Technologies for Sexual and Reproductive Health Symposium, Berkeley California. Available at: http://www.cami-health.com/APT2009/posters.html.
  16. Arntzen C, Herbst-Kralovetz M, Mason H, Tacket C, Khanna N, Zeitlin L, Whaley K The vaccine and microbicide alliance. Presented at the 2009 Advancing Prevention Technologies for Sexual and Reproductive Health Symposium, Berkeley California. Available at: http://www.cami-health.com/APT2009/posters.html.
  17. Alliance for Microbicide Development. HIV/STI Prevention Research and Development: October 2009 Pipeline Update of Microbicide and PrEP Candidates. Silver Spring, MD. Available at: http://www.microbicide.org/uploads/3/1/2/1/3121935/microbicide_pipeline_update_1_oct_2009.pdf.
  18. Nath A, Sitruk-Ware R. Novel non-oral hormonal contraceptive methods for women. Exp Rev Obstet Gynecol. 2009;4:565–573
  19. Bolton M, van der Straten A, Cohen CR. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex Transm Dis. 2008;35:214–225
  20. Liu X, Lagenaur LA, Simpson DA, et al. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob Agents Chemother. 2006;50:3250–3259

PII: S0010-7824(09)00518-6

doi: 10.1016/j.contraception.2009.11.009

Contraception
Volume 81, Issue 3 , Pages 177-180 , March 2010

Article Tools